Table 2. Adjusted cause-specific Hazard Ratios (csHR) on removal due to death or deterioration and transplantation with and without socioeconomic status (SES).
| Due to death/deterioration | Due to Liver Transplant | |||||
|---|---|---|---|---|---|---|
| Adjusted csHR without SES | Adjusted csHR with SES | P value | Adjusted csHR without SES | Adjusted csHR with SES | P value | |
| Race | ||||||
| White | 1 | 1 | 1 | 1 | ||
| Black | 1.076 | 1.053 | 0.004 | 0.964 | 0.978 | 0.067 |
| Hispanic | 1.034 | 0.966 | 0.014 | 0.896 | 0.916 | <.0001 |
| Asian | 1.024 | 1.005 | 0.843 | 1.051 | 1.05 | 0.006 |
| Others | 1.188 | 1.152 | 0.000 | 0.99 | 1.007 | 0.831 |
| Age | 1.031 | 1.031 | <.0001 | 0.999 | 1 | 0.676 |
| Gender (Male vs Female) | 1.084 | 1.109 | <.0001 | 1.074 | 1.064 | <.0001 |
| Albumin | 0.819 | 0.825 | <.0001 | 0.927 | 0.925 | <.0001 |
| Encephalopathy (Yes vs No) | 1.521 | 1.524 | <.0001 | 1.162 | 1.165 | <.0001 |
| Morbid Obesity (Yes vs No) | 1.149 | 1.152 | <.0001 | 0.957 | 0.955 | 0.008 |
| DM type 2 (Yes vs. No) | 1.088 | 1.078 | <.0001 | 0.924 | 0.928 | <.0001 |
| MELD score | 1.063 | 1.063 | <.0001 | 1.085 | 1.085 | <.0001 |
| Portal Vein Thrombosis | 0.909 | 0.919 | 0.000 | 0.880 | 0.88 | <.0001 |
| Karnofsky Performance Status | ||||||
| 80–100 | 1 | 1 | 1 | 1 | ||
| 50–70 | 1.134 | 1.066 | <.0001 | 1.054 | 1.089 | <.0001 |
| 10–40 | 1.562 | 1.464 | <.0001 | 1.471 | 1.521 | <.0001 |
| Diagnosis | ||||||
| Hepatitis C (HCV) | 1 | 1 | 1 | 1 | ||
| Hepatocellular Cancer | 0 | 0 | 0.550 | 3.776 | 3.731 | <.0001 |
| ALD + HCV | 1.114 | 1.081 | <.0001 | 1.098 | 1.107 | <.0001 |
| Alcoholic liver disease | 0.841 | 0.844 | <.0001 | 0.928 | 0.922 | <.0001 |
| Hepatitis B | 0.859 | 0.869 | <.0001 | 1.133 | 1.122 | <.0001 |
| Autoimmune hepatitis | 0.716 | 0.745 | <.0001 | 1.037 | 1.025 | 0.305 |
| Cryptogenic | 0.84 | 0.861 | <.0001 | 1.055 | 1.046 | 0.012 |
| Other metabolic diseases | 0.863 | 0.902 | 0.013 | 1.543 | 1.531 | <.0001 |
| NASH | 0.88 | 0.907 | <.0001 | 1.107 | 1.093 | <.0001 |
| Primary biliary cholangitis | 0.836 | 0.866 | <.0001 | 1.342 | 1.32 | <.0001 |
| PSC | 0.531 | 0.57 | <.0001 | 1.434 | 1.402 | <.0001 |
| Others | 1.052 | 1.073 | <.0001 | 0.937 | 0.932 | <.0001 |
| Recipient highest Education level | ||||||
| Grade school (0–8) | 1 | 1 | ||||
| Hight school (9–12) or GED | 0.997 | 0.89 | 1.009 | 0.63 | ||
| Attended college / technical school | 0.921 | 0.000 | 0.997 | 0.87 | ||
| Associate / Bachelor | 0.871 | <.0001 | 1.011 | 0.56 | ||
| Post-college graduate | 0.759 | <.0001 | 1.036 | 0.11 | ||
| Others/Unknown/Not reported | 0.988 | 0.610 | 0.967 | 0.09 | ||
| Insurance | ||||||
| Private | 1 | 1 | ||||
| Public-Medicaid | 1.2 | <.0001 | 0.914 | <.0001 | ||
| Public-Medicare | 1.068 | <.0001 | 0.867 | <.0001 | ||
| Public-Others | 1.06 | 0.027 | 0.92 | <.0001 | ||
| Others | 1.301 | <.0001 | 1.112 | <.0001 | ||
| Employment (Yes vs No) | 0.882 | <.0001 | 1.056 | <.0001 | ||
ALD—alcoholic liver disease; DM—diabetes mellitus; MELLD—model for end-stage liver disease; NASH—nonalcoholic steatohepatitis; PSC—primary sclerosing cholangitis; SD—standard deviation; SES -socioeconomic status.